# US 2021/0261541 A1 · 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0261541 A1
- Document ID: US20210261541A1
- Status: Published application
- Kind: A1
- Application number: 17/161,201
- Filed: 2021-01-28
- Published: 2021-08-26
- Earliest claimed: 2016-09-14
- Assignees: Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft
- Applicants: Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft
- Inventors: Henrik TELLER; Alexandros VAKALOPOULOS; Melissa BOULTADAKIS ARAPINIS; Alexander STRAUB; Hanna TINEL; Markus BRECHMANN; Matthias Beat WITTWER; Maximillian Andreas KULLMANN; Till FREUDENBERGER; Thomas MONDRITZKI; Tobias MARQUARDT
- Web page: https://patentgrep.com/patent/US20210261541A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61K 31/4375: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A61K 31/551: having two nitrogen atoms, e.g. dilazep
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/06: Antiarrhythmics
- A61P 13/00: Drugs for disorders of the urinary system
- C07D 491/107: with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.

## Claims

### Claim at position 1

1-7. (canceled)

### Claim at position 2

8: A compound of formula (II)
wherein
X is halogen;
R2 is a group of the formula
wherein
* marks the point of attachment to the nitrogen atom of the amide moiety,
R6A is hydrogen or (C1-C4)-alkyl,
R6B is hydrogen, (C1-C4)-alkyl, cyclopropyl, monofluoromethyl, difluoromethyl, trifluoromethyl, methoxymethyl or trifluoromethoxymethyl,
L1 is a bond or a group of the formula —C(R8AR8B)—(C(R9AR9B))m—,
wherein
m is 0 or 1,
R8A is hydrogen or methyl,
R8B is hydrogen, methyl, trifluoromethyl, pentafluoroethyl or trifluoromethoxymethyl,
R9A and R9B are independently hydrogen or methyl,
Ar2 is phenyl,
wherein phenyl is optionally mono- to trisubstituted, identically or differently, by fluorine, chlorine, (C1-C3)-alkyl, difluoromethoxymethyl, trifluoromethoxymethyl or trifluoromethyl,
or
Ar2 is a 5- to 10-membered monocyclic, bicyclic or tricyclic carbocycle or heterocycle which optionally contains one or two further identical or different heteroatoms from the group consisting of N and O as ring members,
wherein the 5- to 10-membered monocyclic, bicyclic or tricyclic carbocycle or heterocycle is optionally up to trisubstituted by identical or different substituents from the group consisting of (C1-C3)-alkyl, trifluoromethyl and (C1-C4)-alkoxycarbonyl and furthermore up to tetrasubstituted by fluorine,
and
Hal represents is fluorine, chlorine, bromine or iodine, preferably chlorine.

### Claim at position 3

9: A compound of formula (IV)
wherein
X is halogen;
R1 is hydrogen,
or
is —NR4R5,
wherein
R4 is hydrogen, methyl, (C2-C4)-alkyl or (C3-C6)-cycloalkyl,
wherein (C2-C4)-alkyl is optionally substituted by hydroxyl or up to trisubstituted by fluorine;
and
R5 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, 3- to 6-membered saturated heterocyclyl or (C1-C4)-alkylsulfonyl,
wherein (C1-C6)-alkyl, (C3-C6)-cycloalkyl and 3- to 6-membered saturated heterocyclyl are optionally up to trisubstituted, identically or differently, by methyl, difluoromethyl, trifluoromethyl, hydroxyl, hydroxycarbonyl, oxo, methoxy, difluoromethoxy, trifluoromethoxy or cyano, and additionally up to tetrasubstituted by fluorine,
or
R4 and R5 together with the nitrogen atom to which they are bonded form a saturated or partially unsaturated, 3- to 6-membered monocyclic or 6- to 10-membered bicyclic heterocycle which optionally contains one or two further, identical or different heteroatoms selected from the group of N, O, S, SO and SO2 as ring members,
wherein the 3- to 6-membered monocyclic and the 6- to 10-membered bicyclic heterocycle are optionally substituted by 1 to 5 substituents independently selected from the group consisting of (C1-C4)-alkyl, difluoromethyl, trifluoromethyl, hydroxy, hydroxycarbonyl, oxo, (C1-C4)-alkoxy, difluoromethoxy, trifluoromethoxy, cyano, (C1-C4)-alkoxycarbonyl, aminocarbonyl, mono-(C1-C3)-alkylaminocarbonyloxy, —NHC(═O)R14A, —CH2NHC(═O)R14B, —OC(═O)R15, and additionally up to tetrasubstituted by fluorine,
wherein (C1-C4)-alkyl is optionally mono- or disubstituted, identically or differently, by hydroxyl and (C1-C3)-alkoxy, and up to tetrasubstituted by fluorine,
R14A and R14B are independently (C1-C4)-alkyl or cyclopropyl,
and wherein
R15 is (C1-C4)-alkyl,
Ar1 is selected from the group consisting of
wherein
*** marks the point of attachment to the nitrogen atom.

### Claim at position 4

10-15. (canceled)

### Claim at position 5 (depends on 8)

16: The compound of claim 8, wherein Hal is chlorine.
